Effectiveness of Companion-Intensive Multi-aspect Weight Management in Chinese Adults with Obesity: A Six-Month Multicenter Randomized Clinical Trial

Wanzi Jiang, Shushu Huang, Shuai Ma, Yingyun Gong, Zhenzhen Fu, Li Zhou, Wen Hu, Guofang Mao, Zhimin Ma, Ling Yang, Guangfeng Tang, Xiaofang Sun, Ping Zhang, Jianling Bai, Lei Chen, Bimin Shi, Xinhua Ye, Hongwen ZhouResearch Square 2020 · DOI

Introduction

Obesity has evolved into a global health epidemic, necessitating early and effective lifestyle interventions to mitigate long-term metabolic risks. While intensive lifestyle modification remains the "gold standard" for treatment, maintaining such changes is notoriously difficult. In China, traditional weight management often relies on sporadic face-to-face clinical visits, which frequently result in poor adherence and subsequent weight regain. This study, originally published in Nutrition & Metabolism, evaluates whether a "Companion-Intensive" approach—leveraging digital supervision—can overcome these barriers.

Study Design and Methodology

This six-month, prospective, open-label, multicenter, randomized controlled trial recruited 272 obese Chinese adults (BMI $\ge$ 28.0 kg/m²) aged 18–50. Participants were randomized into two intervention arms:

  1. Companion-Intensive Multi-aspect Weight Management (CIMWM): This group received monthly face-to-face guidance from a multidisciplinary team (physicians, dietitians, and health managers) supplemented by daily online instructions and real-time supervision via a smartphone application.
  2. Traditional Multi-aspect Weight Management (TMWM): This control group received the same monthly face-to-face guidance and meal replacements but relied on daily self-monitoring without the real-time digital feedback loop.

The intervention phase (Months 1–3) utilized an individualized calorie-restricted diet (1200–1800 kcal/day), high-protein/fiber meal replacements, and a structured exercise plan (160 minutes/week). During the maintenance phase (Months 4–6), both groups transitioned to self-monitoring to assess the durability of the initial intervention.

Key Findings

Superior Weight Loss and BMI Reduction

The CIMWM strategy proved significantly more effective than traditional methods. By the end of the six-month study, 66.7% of the CIMWM group achieved a clinically significant weight loss of $\ge$ 5%, compared to 54.2% in the TMWM group ($P=0.042$). Furthermore, the CIMWM group demonstrated a significantly greater reduction in BMI at the 2, 3, and 6-month intervals compared to the control group.

Improved Body Composition and Metabolic Markers

Beyond total weight loss, the study emphasized the quality of weight reduction. The CIMWM group showed superior improvements in several key areas:

  • Visceral Fat Area (VFA): A critical marker for metabolic disease, VFA reduction was significantly greater in the CIMWM group at the 3-month mark.
  • S/V Ratio: The skeletal muscle mass-to-visceral fat area ratio improved significantly more in the CIMWM group. This ratio serves as a vital proxy for metabolic health and is inversely related to the risk of Non-Alcoholic Fatty Liver Disease (NAFLD).
  • Lipid Profiles: Total cholesterol (TC) levels remained markedly lower in the CIMWM group throughout the trial ($P<0.05$).

The "Metabolic Memory" Effect

A striking observation was the persistence of benefits during the maintenance phase. Despite the cessation of daily intensive guidance after month 3, the CIMWM group continued to exhibit superior reductions in BMI, body fat mass, and total cholesterol at month 6. This suggests that the three-month "companion" phase successfully reprogrammed participants' lifestyles and habits, creating a "metabolic memory" that sustained progress even during the self-monitoring phase.

Liver Health and Fibrosis Risk

Using the NAFLD Fibrosis Score (NFS), researchers found that weight management was particularly effective for high-risk individuals. Participants in the highest tertile of NFS at baseline saw significant reductions in their scores following the intervention, highlighting the potential for lifestyle reprogramming to reverse early markers of liver damage.

Discussion and Limitations

The study underscores the power of the "digital companion" in bridging the gap between clinical advice and daily execution. The real-time expert feedback provided to the CIMWM group likely fostered higher accountability and better adherence to the prescribed diet and exercise regimens.

However, the authors noted several limitations. The open-label design, necessitated by the nature of the digital intervention, could introduce bias. Additionally, liver health was assessed via calculated scores (NFS) rather than direct imaging like MRI or FibroScan. Future research should focus on long-term sustainability (12–24 months) and the use of high-resolution tracking for physical activity intensity.

Conclusion

The Companion-Intensive Multi-aspect Weight Management (CIMWM) strategy is a highly effective model for treating obesity in Chinese adults. By combining traditional clinical expertise with daily digital companionship, this approach not only achieves superior weight loss and metabolic improvements but also motivates the long-term lifestyle changes necessary to combat the obesity epidemic.

Summary updated

Abstract

<title>Abstract</title> <bold>Background: </bold>Obesity is a globally increasing health epidemic requiring early lifestyle intervention. Our main objective was to examine the effectiveness of companion-intensive multi-aspect weight management (CIMWM) in Chinese adults with obesity.<bold>Methods: </bold>In this 6-month, prospective, open-label, multicenter, randomized controlled clinical trial, we recruited 272 obese adults aged 18–50 years with a body mass index (BMI) ≥28.0 kg/m<sup>2</sup> and capable of using smartphones. CIMWM (n=136) offered both daily online instructions and monthly face-to-face guidance by physicians, dietitians, and health managers along with the provision of meal replacements in the first 3 months. Traditional multi-aspect weight management (TMWM, n=136) provided monthly face-to-face guidance by the same panel of professionals and the same meal replacements as CIMWM group, but required subjects to complete daily self-monitoring instead of offering daily online instructions. Body composition and metabolic parameters were assessed at baseline, 1, 2, 3, and 6 months by physicians. Primary outcomes were the clinically-significant weight loss and changes in BMI and body composition.<bold>Results: </bold>Participants in both groups showed significantly reduced BMI, body fat mass (BFM), visceral fat area (VFA), and HOMA-IR (P&lt;0.05). CIMWM was shown to be superior to TMWM in the improvement of clinically-significant weight loss, BMI, total cholesterol (TC), the body composition parameters BFM and the skeletal muscle mass-to-visceral fat area ratio (S/V) (P&lt;0.05). The non-alcoholic fatty liver disease score (NFS) was negatively related to S/V at baseline. After weight management, NFS was lowered among individuals with levels in the highest tertile (P&lt;0.05). Metabolic memory in terms of the continuous reduction of BMI, BFM, and TC was retained up to 6 months in spite of participants transferring to self-monitoring assessment in the final 3 months.<bold>Conclusions: </bold>The CIMWM strategy in obese Chinese adults is proved to be more effective than TMWM in weight loss, and motivates greater adherence to intervention and lifestyle reprogramming.<bold>Trial registration: </bold>Chinese Clinical Trial Registry, ChiCTR1800017463, Registered July 31, 2018, retrospectively registry. http://www.chictr.org.cn/showproj.aspx?proj=29649
BibTeX
@inproceedings{jiang2020effectiveness,
  author = {Wanzi Jiang and Shushu Huang and Shuai Ma and Yingyun Gong and Zhenzhen Fu and Li Zhou and Wen Hu and Guofang Mao and Zhimin Ma and Ling Yang and Guangfeng Tang and Xiaofang Sun and Ping Zhang and Jianling Bai and Lei Chen and Bimin Shi and Xinhua Ye and Hongwen Zhou},
  title = {{Effectiveness of Companion-Intensive Multi-aspect Weight Management in Chinese Adults with Obesity: A Six-Month Multicenter Randomized Clinical Trial}},
  booktitle = {Research Square},
  year = {2020},
  doi = {10.21203/rs.3.rs-31448/v2},
}
Figure